A Novel Acyl-CoA: Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor, GSK2973980A, Inhibits Postprandial Triglycerides and Reduces Body Weight in a Rodent Diet-induced Obesity Model

Journal Title: Journal of Pharmaceutical Research International - Year 2017, Vol 18, Issue 6

Abstract

Background and Aim: Acyl-CoA: diacylglycerol acyltransferase 1 (DGAT1) is a key enzyme catalyzing the final step of triglyceride (TG) synthesis and is implicated in fat absorption and disposition. However, development of several DGAT1 inhibitors has been hampered due to unacceptable gastrointestinal (GI) tolerability observed in clinical trials. Our aim is to develop a novel, potent and selective DGAT1 inhibitor that reduces plasma TG levels and body weight with acceptable GI tolerability in a rodent model of obesity. Study Design: In vitro enzyme and cellular assays as well as in vivo experimental studies in mice and rat examining the effect of drugs on triglycerides, fecal fat, body weight and food intake. Place and Duration of Study: Virtual proof of concept, GSK USA & Cellzome, GSK Germany and Collaborative research, GVK, India between 2011-2017. Methodology: A radiometric assay of TG formation evaluated DGAT activity and a thermal shift assay determined target specificity. Fasted mice received an oral corn oil bolus to model hypertriglyceridemia. Intralipid administration in fasted rats was used to evaluate triglyceride clearance. Mice were fed a high fat diet to induce obesity. Results: Herein, we describe GSK2973980A as a novel, potent and selective DGAT1 inhibitor that reduced plasma TG levels in postprandial lipid excursion and impaired clearance studies in rodents and reduced body weight and food intake in obese mice. Interestingly, robust plasma TG reduction was accompanied by varying degrees of fecal lipid excretion. Alternate dosing via the subcutaneous route maintained a significant effect on plasma TG reduction with no altered fecal lipid excretion, suggesting GI tolerability may be modulated by limiting local GI exposure of DGAT1 inhibitors. Conclusion: Our data suggest that the impaired TG clearance model in the rat can be used to identify DGAT1 inhibitors with potentially better GI tolerability.

Authors and Affiliations

Sanjay Kumar, Vijaya G. Tirunagaru, Jennifer Ariazi, Amit Awasthi, Venkatesh Babu Jayaraman, Premkumar Arumugam, Mahesh Yanamandra, Sayan Mitra, Sudhir Tiwari, Raghuram S. Tangirala, Thilo Werner, Douglas Thomson, Giovanna Bergamini, Mui Cheung

Keywords

Related Articles

Evaluation, Formulation and Optimization Study of Myrrh (Commiphora myrrha) Resin as Rate Controlling Excipient in Sustained Release Matrix Tablets of Theophylline

Aims: To investigate myrrh (Commiphora myrrha) resin as a rate controlling excipient in sustained release matrix tablets of theophylline, and to optimize formulation and process variables of the tablet preparation using...

Evaluation of Thrombolytic Effect of Seven Different Bangladeshi Plants

Aim: From time past till date, proper documentation of the use of medicinal plants are helpful in drug development and research. The objective of this study is to evaluate several plant extracts of Bangladesh for their t...

In vitro Evaluation of Antidiabetic and Anti-Inflammatory Activity of Ethanolic and Methanolic Extracts of Ceropegia juncea

Antidiabetic and anti-inflammatory activity of ethanol and methanol extracts of in vivo and in vitro plants of Ceropegia juncea were evaluated by in vitro methods. Antidiabetic activity was studied using α-amylase inhibi...

Study of Preventive Effectiveness of Nigella sativa L. against Rat kidney Stones, Generated by Ethylene Glycol

Aims: The objective of this research is to study the preventive effectiveness of Nigella sativa L. against rat kidney stones, generated by Ethylene Glycol. Methodology: In this study, 40 Wistar rats were categorized r...

Extracts of Eastern Nigeria Mistletoe, Tapinanthus globiferus (A. Rich.) Tiegh. Modulate Dexamethasone-induced Insulin Resistance and Exhibit Potent osteogenic Activity in Animal Experimental Model

Ethnopharmacological Relevance: Scientific evidence for the traditional use of eastern Nigeria mistletoe as an anti-diabetic and anti-osteoporotic agent has been documented. In our continued efforts to provide further ev...

Download PDF file
  • EP ID EP313127
  • DOI 10.9734/JPRI/2017/36835
  • Views 79
  • Downloads 0

How To Cite

Sanjay Kumar, Vijaya G. Tirunagaru, Jennifer Ariazi, Amit Awasthi, Venkatesh Babu Jayaraman, Premkumar Arumugam, Mahesh Yanamandra, Sayan Mitra, Sudhir Tiwari, Raghuram S. Tangirala, Thilo Werner, Douglas Thomson, Giovanna Bergamini, Mui Cheung (2017). A Novel Acyl-CoA: Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor, GSK2973980A, Inhibits Postprandial Triglycerides and Reduces Body Weight in a Rodent Diet-induced Obesity Model. Journal of Pharmaceutical Research International, 18(6), 1-15. https://europub.co.uk/articles/-A-313127